The Lipid-Lowering Agents market in Bosnia and Herzegovina has been experiencing steady growth in recent years.
Customer preferences: Customers in Bosnia and Herzegovina are increasingly becoming health-conscious and are seeking ways to manage their cholesterol levels. This has led to a rise in demand for lipid-lowering agents.
Trends in the market: One of the major trends in the Lipid-Lowering Agents market in Bosnia and Herzegovina is the increasing use of statins. Statins are the most commonly prescribed lipid-lowering agents in the country due to their effectiveness and affordability. Additionally, there has been a growing interest in natural lipid-lowering supplements, such as plant sterols and stanols, as more customers are looking for natural alternatives to prescription drugs.
Local special circumstances: One of the unique challenges in the Lipid-Lowering Agents market in Bosnia and Herzegovina is the lack of awareness among the general public about the importance of managing cholesterol levels. This has led to a low diagnosis rate of hypercholesterolemia, which in turn affects the demand for lipid-lowering agents. However, the government has been taking steps to increase awareness about the importance of managing cholesterol levels and has been promoting healthy lifestyle habits.
Underlying macroeconomic factors: The economic stability of Bosnia and Herzegovina has a significant impact on the Lipid-Lowering Agents market. The country's GDP has been steadily growing in recent years, which has led to an increase in disposable income and a rise in demand for healthcare products. Additionally, the government has been investing in the healthcare sector, which has led to an improvement in the quality of healthcare services and an increase in access to medication. These factors have contributed to the growth of the Lipid-Lowering Agents market in Bosnia and Herzegovina.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
